[1]
N. Filipets, D. Ivanov, and A. Gozhenko, “Renin-angiotensin-aldosterone system blockers as the main pathogenetic approach of drug nephroprotection”, KIDNEYS, vol. 8, no. 1, pp. 34–39, Sep. 2021.